Related Experiment Video
Updated: Aug 23, 2026

Murine Full-thickness Skin Transplantation
Published on: January 2, 2017
New drugs to improve transplant outcomes
M Roy First1, William E Fitzsimmons
1Fujisawa Healthcare, Inc., Deerfield, IL 60015, USA.
Abstract:
Fujisawa is committed to improving the outcomes of transplant patients worldwide. Research and development programs are underway for a new modified release dosage form of tacrolimus (MR-4), a new analog of leflunomide (FK 778), and several novel compounds (PG 490-88, AGI 1096) in collaboration with other companies. These programs are targeted to address many of the unmet medical needs in transplantation including (1) improving compliance, (2) reducing chronic rejection, and (3) improving long-term safety by reducing infectious and cardiovascular risk.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant II: Surgical Procedure
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

